Should you care about the Valeant drama?

This morning, a hedge fund manager with a large position in embattled pharma company Valeant held a three hour conference call to assuage investor concerns about its 50% crash over the last few months.

It’s not working so far, the stock is bleeding all over the exchange as of this posting.

My take on whether or not investors should care about Valeant and its developing situation just went live at Fortune today. Read it at the link below:

The stock that ate Wall Street (Fortune)